ArticleCentrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner

Add time:08/17/2019    Source:sciencedirect.com

Neurotensin injected intracerebroventricularly at the dose of 30 ng per rat was without intrinsic effect on locomotion. When associated with the enkephalinase inhibitor thiorphan (50 μg, intracerebroventricular) it decreased locomotor activity. On the contrary, the 3 μg dose of NT, which had a tendency to decrease locomotion, stimulated locomotor activity when associated with thiorphan (50 μg, intracerebroventricular). This effect was independent of endogenous enkephalins since it was not suppressed by a high dose of naloxone (2 mg/kg). Similarly, increasing doses of the enkephalinase-resistant peptide [D-Trp11]neurotensin had a biphasic effect on locomotion since doses lower than 60 ng were hypokinetic whereas higher doses were hyperkinetic. This latter effect was not modified by thiorphan. It was antagonized by the dopamine antagonist haloperidol (50 μg/kg, IP).

We also recommend Trading Suppliers and Manufacturers of [D- TRP11 ]-NEUROTENSIN (cas 100929-52-0). Pls Click Website Link as below: cas 100929-52-0 suppliers

Prev:Locomotor sensitization to [d-Trp11]neurotensin after repeated injections of the dopamine uptake inhibitor GBR12783 in rats
Next:ArticleTolerance to the hypothermic but not to the analgesic effect of [d-Trp11]neurotensin during the semichronic intracerebroventricular infusion of the peptide in rats)